
Top psychiatric drugs in the United States by sales 2016
This statistic displays the some of the best-selling psychiatric drugs in the United States during 2016. During this period, Lyrica generated a revenue of some 4.4 billion U.S. dollars. Lyrica is an anticonvulsant drug marketed by Pfizer. In the United States, it is most commonly used for neuropathic pain.